TransCode Therapeutics's market cap is currently $9.48M. The company's EPS TTM is $-56.608; its P/E ratio is ―; TransCode Therapeutics is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is $-105.93. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in USD
TransCode Therapeutics Earnings and Revenue History
